Leukemia Home > Marquibo
Were you looking for information about Marqibo? Marquibo is a common misspelling of Marqibo.
If you have a form of cancer called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL), your healthcare provider may prescribe a chemotherapy drug called Marqibo® (liposomal vincristine sulfate). The medication is approved for use in adults, and is prescribed when at least two other forms of leukemia treatment have been tried and the cancer has returned or become worse.
Marqibo is injected into a vein (intravenously, or by IV) once every seven days by your healthcare provider. Side effects are common and may include constipation, nausea, and fatigue.
(Click Marqibo for more information on possible side effects, as well as safety precautions to review and factors affecting your dose. You can also click any of the links in the box to the right for specific information.)